Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Skin Neoplasms × Blood Specimen Collection × Clear all

Phase

Status

Recruiting 3 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 43 Neoplasms 28 Colorectal Neoplasms 20 Prostatic Neoplasms 12 Neoplastic Cells, Circulating 11 Melanoma 11 Multiple Myeloma 10 Lung Neoplasms 10 Pancreatic Neoplasms 9 Uterine Cervical Neoplasms 7 Ovarian Neoplasms 7 Colonic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Leukemia, Myeloid, Acute 6 Hematologic Neoplasms 6 Uveal Melanoma 5 Papillomavirus Infections 5 Neoplasm Metastasis 5 Lymphoma 5 Head and Neck Neoplasms 5 Glioma 5 Sarcoma 4 COVID-19 4 Urinary Bladder Neoplasms 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms, Plasma Cell 3 Liver Neoplasms 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia 3

Interventions

aldesleukin 8 Interleukin-2 8 Dacarbazine 6 fludarabine phosphate 5 Cyclophosphamide 5 fludarabine 4 Temozolomide 4 Nivolumab 4 Ipilimumab 4 montanide ISA 51 3 Surveys and Questionnaires 3 Semaxinib 3 Radiotherapy 3 Radiation 3 Fluorouracil 3 Educational Status 3 zanolimumab 2 sonidegib 2 poly ICLC 2 binimetinib 2 Whole-Body Irradiation 2 Vinblastine 2 Vemurafenib 2 Surgical Procedures, Operative 2 Spectrum Analysis, Raman 2 Sodium Chloride 2 Photochemotherapy 2 Peptides 2 Optical Imaging 2 Mohs Surgery 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07422805 2026-02-24

ctDNA

Institute of Oncology Ljubljana

Phase NA Completed

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡